Home AEC Tenaya Therapeutics Completes 94,000 SQFT Genetic Medicines Manufacturing Center in Union City
AECCommercialINDUSTRY newsLife ScienceNews Releases

Tenaya Therapeutics Completes 94,000 SQFT Genetic Medicines Manufacturing Center in Union City

Share
Share

Facility to Provide Clinical Supply of Lead Gene Therapy Programs TN-201 and TN-401 for Planned First-in-Human Studies 94,000 sq. ft. Modular Facility has Initial Production Capacity at the 1000L Scale (EDITOR’S NOTE: The company leased the property, located at 33498 Central Avenue in Union City, in February 2021 from Terreno Realty, according to public records. […]

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Partner Content

2026 Northern California CRE Rising Stars

NorCal rising stars 2026

Partner Content


Recent Posts

Related Articles

Beacon Capital Partners Sells 241,000 SQFT RATIO Innovation Campus in Emeryville for $63.5MM, Half Its 2020 Price

Beacon Capital Partners has offloaded the two-building RATIO Innovation Campus in Emeryville...

Seven Equity Group Selected to Buy Shuttered 1.5MM SQFT San Francisco Centre

New York-based Seven Equity Group, a specialist in repositioning distressed retail, has...

San Francisco Class B Office Effective Rents Jump 15%, Outpacing Class A as Mid-Tier Space Leads Q3 Absorption

Mid-tier office buildings outran San Francisco's top towers in the third quarter,...

Swift Real Estate Defaults on $194MM Loan Tied to 572,000 SQFT 1111 Broadway Tower in Oakland

A notice of default on the 24-story Class A tower lets Brookfield’s...